سعر ايزوميبكس 40 مجم per vial 2022

Powder for intravenous infusion (vial) containing esomeprazole 40 mg; International Drug Agency (IDI) > Novell Pharma; pack of 1 vial.

• Short-term treatment of GERD with erosive esophagitis when oral therapy is not possible (adults and children 1 month-17 years); risk reduction of rebleeding of gastric or duodenal ulcers after therapeutic endoscopy (adults) (US label).DailyMed (U.S. National Library of Medicine)

• Most common (>=1%) with IV esomeprazole: headache, flatulence, nausea, abdominal pain, injection site reaction, diarrhea, dry mouth, dizziness/vertigo, constipation, pruritus (US label).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to substituted benzimidazoles or any component (reactions may include anaphylaxis, angioedema, bronchospasm, acute tubulointerstitial nephritis, urticaria); concomitant rilpivirine-containing products (US label).General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Symptomatic response does not exclude gastric malignancy; acute tubulointerstitial nephritis; Clostridioides difficile-associated diarrhea; osteoporosis-related fractures with long-term/high-dose use; severe cutaneous adverse reactions; cutaneous and systemic lupus erythematosus; hypomagnesemia with prolonged use; avoid with clopidogrel and with St John's wort or rifampin; increased chromogranin A may interfere with neuroendocrine tumour tests; fundic gland polyps with long-term use (US label).General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• ClopidogrelReduced antiplatelet effect through CYP2C19 inhibition; avoid concomitant use.DailyMed (U.S. National Library of Medicine)
• RilpivirineContraindicated: reduced rilpivirine exposure and possible loss of virologic response.DailyMed (U.S. National Library of Medicine)
• St John's wort, rifampinDecreased esomeprazole exposure; avoid concomitant use.DailyMed (U.S. National Library of Medicine)

• US label: no adequate and well-controlled studies in pregnant women; epidemiological data with first-trimester omeprazole (racemate) show no increased risk of major congenital malformations; no teratogenicity in animal studies with oral esomeprazole magnesium.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• US label: limited data suggest omeprazole may be present in human milk; no data on effects on the breastfed infant or milk production; weigh benefits of breastfeeding against maternal need.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Esomeprazole: S-isomer of omeprazole; inhibits the gastric H+/K+-ATPase (proton pump) of parietal cells, suppressing basal and stimulated acid secretion (US NEXIUM label).